Management of sulphone-resistant lepromatous leprosy.
作者信息
Jopling W H
出版信息
Lepr Rev. 1977 Jun;48(2):127-8. doi: 10.5935/0305-7518.19770015.
PMID:330998
Abstract
摘要
相似文献
1
Management of sulphone-resistant lepromatous leprosy.
Lepr Rev. 1977 Jun;48(2):127-8. doi: 10.5935/0305-7518.19770015.
2
The diagnosis and management of dapsone-resistant leprosy.耐氨苯砜麻风病的诊断与管理
Lepr Rev. 1977 Jun;48(2):95-105. doi: 10.5935/0305-7518.19770011.
3
Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.氯法齐明治疗由耐氨苯砜麻风杆菌引起的瘤型麻风。
Am J Trop Med Hyg. 1972 May;21(3):315-21. doi: 10.4269/ajtmh.1972.21.315.
4
Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
Int J Lepr Other Mycobact Dis. 1974 Oct-Dec;42(4):416-418.
5
Combined clofazimine- and dapsone-resistant leprosy. A case report.氯法齐明和氨苯砜联合耐药性麻风病。病例报告。
Int J Lepr Other Mycobact Dis. 1986 Sep;54(3):389-91.
6
Dapsone drug resistance in the MDT era.多药联合治疗时代的氨苯砜耐药性。
Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):323-5.
7
Sulphone resistance and its implications.砜类耐药性及其影响。
Lepr Rev. 1977 Jun;48(2):123-5. doi: 10.5935/0305-7518.19770014.
8
Sulphone resistance in leprosy. A review of one hundred proven clinical cases.
Lancet. 1975 Jul 12;2(7924):69-72. doi: 10.1016/s0140-6736(75)90508-5.
9
Secondary sulphone resistance in leprosy (Report of a case).麻风病的继发性砜类耐药性（1例报告）
Lepr India. 1980 Apr;52(2):299-301.
10
Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
Lepr Rev. 1975 Jun;46(2 Suppl):69-72. doi: 10.5935/0305-7518.19750042.
Zotero 插件